2024-12-30 03:24:25
Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity
Health/ 2023-07-22
Sciwind Biosciences Announces Positive I...

- Mean body weight loss of 11.1% in participants receiving once-weekly injections of 2.4 mg XW003 for 18 weeks

First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials
Health/ 2023-07-22
First satellite bioanalytical lab offers...

THEBARTON,Australia,Oct. 26,2022--On 09 September 2022,Australia welcomed its first bioanalytical laboratory inside a Phase 1 clinical unit.

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release